The use of antidepressants had always been associated with abnormalities of dna in deaths of newborns. But a new study reveals that the use of antidepressants during pregnancy is not associated with higher risk of infant mortality at birth, according to the study.
A Swedish study was conducted on nearly 30,000 women and observed 1.6 million births in five countries. Researchers found that 1.79 per cent of mothers who used SSRIs (Selective Serotonin Reuptake Inhibitors) have an increased risk of infant mortality in childbirth higher than those not using SRRI.
However, this is known as a result of mental illness such as depression, and not caused by drugs.
Meanwhile, smoking habits and old age in women is also often associated with high rates of stillbirths. In this case, mothers who uses SRRI are known to have the same risk with mothers who do not use SRRI.
“SRRI use during pregnancy is not associated with increased infant mortality at birth,” said lead researcher Olof Stephansson, from the Karolinska Insitutet in Stockholm, as reported by the NY Daily News.
Even so, Adam Urato, an expert from Tufts University School of Medicine pleaded that he is not overly convinced by the research. According to him, the study did not look at the use of drugs consumed by patients, and observed a completely different number.